Livzon Pharmaceutical Group Inc (000513) — Cash Flow Reinvestment Rate
Livzon Pharmaceutical Group Inc (000513) has a Cash Flow Reinvestment Rate of 0.44x as of December 2025, reinvesting CN¥276.99 Million (capex CN¥78.72 Million plus investments CN¥-198.26 Million) from operating cash flow of CN¥625.70 Million. See Livzon Pharmaceutical Group Inc (000513) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Livzon Pharmaceutical Group Inc Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Livzon Pharmaceutical Group Inc across 27 annual periods. For the full cash flow conversion analysis, see how efficiently does Livzon Pharmaceutical Group Inc generate cash.
Annual Cash Flow Reinvestment Rate for Livzon Pharmaceutical Group Inc (1999–2025)
Year-by-year capital reinvestment analysis for Livzon Pharmaceutical Group Inc. See Livzon Pharmaceutical Group Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.60x | CN¥1.90 Billion | CN¥3.18 Billion | CN¥574.14 Million | ▲ +171.0% |
| 2024 | 0.22x | CN¥656.96 Million | CN¥2.98 Billion | CN¥570.16 Million | ▼ -53.1% |
| 2023 | 0.47x | CN¥1.53 Billion | CN¥3.25 Billion | CN¥820.45 Million | ▼ -39.9% |
| 2022 | 0.78x | CN¥2.17 Billion | CN¥2.77 Billion | CN¥940.15 Million | ▼ -25.0% |
| 2021 | 1.04x | CN¥1.98 Billion | CN¥1.90 Billion | CN¥1.31 Billion | ▲ +202.3% |
| 2020 | 0.35x | CN¥745.73 Million | CN¥2.16 Billion | CN¥646.98 Million | ▲ +52.6% |
| 2019 | 0.23x | CN¥399.55 Million | CN¥1.77 Billion | CN¥398.00 Million | ▼ -71.3% |
| 2018 | 0.79x | CN¥997.34 Million | CN¥1.27 Billion | CN¥474.47 Million | ▲ +32.8% |
| 2017 | 0.59x | CN¥779.77 Million | CN¥1.32 Billion | CN¥294.15 Million | ▼ -42.2% |
| 2016 | 1.03x | CN¥1.31 Billion | CN¥1.28 Billion | CN¥368.46 Million | ▲ +70.5% |
| 2015 | 0.60x | CN¥557.97 Million | CN¥927.79 Million | CN¥477.13 Million | ▼ -35.2% |
| 2014 | 0.93x | CN¥665.52 Million | CN¥717.39 Million | CN¥665.52 Million | ▼ -55.6% |
| 2013 | 2.09x | CN¥920.00 Million | CN¥439.99 Million | CN¥920.00 Million | ▲ +62.9% |
| 2012 | 1.28x | CN¥762.30 Million | CN¥593.96 Million | CN¥762.30 Million | ▲ +160.6% |
| 2011 | 0.49x | CN¥348.83 Million | CN¥708.20 Million | CN¥348.83 Million | ▼ -7.4% |
| 2010 | 0.53x | CN¥336.95 Million | CN¥633.30 Million | CN¥336.95 Million | ▲ +100.4% |
| 2009 | 0.27x | CN¥131.41 Million | CN¥494.88 Million | CN¥131.41 Million | ▲ +21.4% |
| 2008 | 0.22x | CN¥75.52 Million | CN¥345.18 Million | CN¥75.52 Million | ▼ -40.4% |
| 2007 | 0.37x | CN¥91.28 Million | CN¥248.55 Million | CN¥91.28 Million | ▼ -53.9% |
| 2006 | 0.80x | CN¥180.45 Million | CN¥226.46 Million | CN¥180.45 Million | ▼ -50.0% |
| 2005 | 1.59x | CN¥256.72 Million | CN¥161.07 Million | CN¥256.72 Million | ▲ +97.4% |
| 2004 | 0.81x | CN¥146.48 Million | CN¥181.46 Million | CN¥146.48 Million | ▲ +133.9% |
| 2003 | 0.35x | CN¥103.56 Million | CN¥300.01 Million | CN¥103.56 Million | ▼ -28.8% |
| 2002 | 0.48x | CN¥103.62 Million | CN¥213.65 Million | CN¥103.62 Million | ▼ -7.7% |
| 2001 | 0.53x | CN¥81.48 Million | CN¥155.15 Million | CN¥81.48 Million | ▼ -67.1% |
| 2000 | 1.60x | CN¥61.49 Million | CN¥38.52 Million | CN¥61.49 Million | ▲ +435.3% |
| 1999 | 0.30x | CN¥73.44 Million | CN¥246.23 Million | CN¥73.44 Million | — |